These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37764933)

  • 1. Bloodstream Infections by AmpC-Producing Enterobacterales: Risk Factors and Therapeutic Outcome.
    Pospišil M; Car H; Elveđi-Gašparović V; Beader N; Herljević Z; Bedenić B
    Pathogens; 2023 Sep; 12(9):. PubMed ID: 37764933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing
    Stewart AG; Paterson DL; Young B; Lye DC; Davis JS; Schneider K; Yilmaz M; Dinleyici R; Runnegar N; Henderson A; Archuleta S; Kalimuddin S; Forde BM; Chatfield MD; Bauer MJ; Lipman J; Harris-Brown T; Harris PNA;
    Open Forum Infect Dis; 2021 Aug; 8(8):ofab387. PubMed ID: 34395716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase.
    Kohlmann R; Bähr T; Gatermann SG
    J Antimicrob Chemother; 2018 Jun; 73(6):1530-1536. PubMed ID: 29566147
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Stewart AG; Cottrell K; Henderson A; Vemuri K; Bauer MJ; Paterson DL; Harris PNA
    Microbiol Spectr; 2021 Sep; 9(1):e0022621. PubMed ID: 34232101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic Treatment of Infections Caused by AmpC-Producing Enterobacterales.
    Tebano G; Zaghi I; Cricca M; Cristini F
    Pharmacy (Basel); 2024 Sep; 12(5):. PubMed ID: 39311133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibilities of isolates of potentially naturally inducible chromosomal AmpC-producing metallo-β-lactamase-negative carbapenem-resistant Enterobacterales species to ceftazidime-avibactam: Data from the Antimicrobial Testing Leadership and Surveillance Programme, 2012-2019.
    Jean SS; Lee YL; Hsu CW; Hsueh PR
    Int J Antimicrob Agents; 2022 Sep; 60(3):106617. PubMed ID: 35718266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Antimicrobial Susceptibility Patterns of ESBL, AmpC and Carbapenemase-producing
    Ghotaslou R; Sadeghi MR; Akhi MT; Hasani A; Asgharzadeh M
    Iran J Pharm Res; 2018; 17(Suppl):79-88. PubMed ID: 29796032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.
    Tello M; Ocejo M; Oporto B; Hurtado A
    Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32471914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea.
    Park YJ; Yu JK; Lee S; Oh EJ; Woo GJ
    J Antimicrob Chemother; 2007 Oct; 60(4):868-71. PubMed ID: 17660263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Carriage of Extended-Spectrum β-Lactamases and pAmpC Producing
    Habibzadeh N; Peeri Doghaheh H; Manouchehri Far M; Alimohammadi Asl H; Iranpour S; Arzanlou M
    Microb Drug Resist; 2022 Sep; 28(9):921-934. PubMed ID: 36067095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone versus cefepime or carbapenems for definitive treatment of low-risk AmpC-Harboring Enterobacterales bloodstream infections in hospitalized adults: A retrospective cohort study.
    Mulbah JL; Kenney RM; Tibbetts RJ; Shallal AB; Veve MP
    Diagn Microbiol Infect Dis; 2024 Oct; 111(1):116557. PubMed ID: 39427451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AmpC β-lactamase-producing Enterobacterales: what a clinician should know.
    Meini S; Tascini C; Cei M; Sozio E; Rossolini GM
    Infection; 2019 Jun; 47(3):363-375. PubMed ID: 30840201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Phoenix Automated Microbiology System for detecting extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, and Serratia marcescens.
    Park YJ; Yu JK; Lee S; Park JJ; Oh EJ
    Ann Clin Lab Sci; 2007; 37(1):75-8. PubMed ID: 17311873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Treatment Outcomes for Bloodstream Infections Caused by Potential AmpC Beta-Lactamase-Producing Enterobacterales with Focus on Piperacillin/Tazobactam: A Retrospective Cohort Study.
    Herrmann L; Kimmig A; Rödel J; Hagel S; Rose N; Pletz MW; Bahrs C
    Antibiotics (Basel); 2021 Jun; 10(6):. PubMed ID: 34199546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porin alterations present in non-carbapenemase-producing Enterobacteriaceae with high and intermediate levels of carbapenem resistance in Chile.
    Wozniak A; Villagra NA; Undabarrena A; Gallardo N; Keller N; Moraga M; Román JC; Mora GC; García P
    J Med Microbiol; 2012 Sep; 61(Pt 9):1270-1279. PubMed ID: 22700549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility evolution to antibiotics of Enterobacter cloacae, Morganella morganii, Klebsiella aerogenes and Citrobacter freundii involved in urinary tract infections: an 11-year epidemiological surveillance study.
    Jiménez-Guerra G; Borrego-Jiménez J; Gutiérrez-Soto B; Expósito-Ruiz M; Navarro-Marí JM; Gutiérrez-Fernández J
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Apr; 38(4):166-169. PubMed ID: 31606242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria.
    Stürenburg E; Lang M; Horstkotte MA; Laufs R; Mack D
    J Antimicrob Chemother; 2004 Nov; 54(5):870-5. PubMed ID: 15471997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.